Linerase Collagen Injections: Equine Type I Collagen for Skin Biostimulation

Long before hyaluronic acid dominated the injectable skin-quality market, collagen itself was used to replenish what ageing skin loses. Linerase, a heterologous (equine) type I collagen system manufactured by the Italian laboratory Euroresearch, revives that approach as a biostimulatory treatment rather than a simple volumiser. For clinics building out a skin-quality menu alongside HA skinboosters and biorevitalisers, it is worth understanding how collagen-based biostimulation differs and where it fits. This overview is educational and does not describe an injection protocol.

What Linerase Is

The injectable component, marketed as Linerase Collagen Booster, is a lyophilised (freeze-dried) powder of purified equine type I collagen, supplied sterile and pyrogen-free in single-use glass vials. It is reconstituted before use and administered by micro-injection. The product carries CE marking as a Class III medical device, and equine-derived collagen of this kind has a long history in wound-care applications, which underpins its safety profile in aesthetic use. As with any heterologous protein, patch testing and a careful allergy history remain standard practice before treatment.

How Collagen Biostimulation Differs From HA

Hyaluronic acid skinboosters and biorevitalisers work primarily by drawing and holding water in the dermis, improving hydration and, over a course, skin quality. Collagen biostimulation with Linerase works differently: introducing exogenous type I collagen is understood to prompt fibroblasts to synthesise new, native type III collagen — a process referred to as neocollagenesis. The aim is a genuine increase in the skin's own structural protein rather than a hydration effect alone, positioning it closer to biostimulators such as poly-L-lactic acid or calcium hydroxylapatite in mechanism, though delivered as a collagen scaffold rather than a stimulatory particulate.

The Wider Skin Regeneration System

Linerase is typically offered as part of a four-stage system rather than as a standalone injectable, which is useful context when planning a skin-quality treatment course:

• A peel-off preparatory mask, formulated with vitamins A and C, hyaluronic acid and peptides, intended to support the epidermis alongside the deeper collagen work.
• The Collagen Booster injectable itself, the biostimulatory step.
• A post-treatment restoring mask, designed to calm the skin and reduce visible downtime after micro-injection.
• A maintenance cream for daily use between sessions, combining antioxidants (vitamin E), regenerating agents (panthenol, hydrolysed collagen) and mild exfoliants (mandelic acid).

For clinics, the system also opens a retail conversation: the maintenance cream gives patients a take-home product that reinforces in-clinic results and supports repeat visits.

Indications Commonly Cited

Practitioners typically consider collagen biostimulation with Linerase for:

• Loss of skin firmness and elasticity on the face, neck, décolletage and hands
• Fine lines associated with reduced dermal collagen
• Adjunctive use in scar and stretch-mark texture, given collagen's established role in tissue repair
• Patients seeking a course-based skin-quality treatment as a complement to volumising fillers

As with most biostimulatory treatments, results are described as building over a course of sessions rather than appearing immediately, with effects commonly reported to persist for a year or more once a course is completed.

Assessment and Safety Considerations

Because Linerase involves an animal-derived protein, patient assessment carries a few specific points beyond the usual injectable checklist. Contraindications commonly cited include pregnancy and breastfeeding, active malignancy, autoimmune disease, uncontrolled diabetes, and a personal history of keloid scarring. Transient redness, swelling, itching or tenderness at injection sites is common and generally resolves within days; patients are typically advised against anti-inflammatory medication in the days following treatment, since it can work against the collagen-synthesis response the treatment is designed to trigger.

Where It Sits on a Skin-Quality Menu

Collagen biostimulation is not a replacement for HA skinboosters or biorevitalisers so much as an alternative mechanism aimed at the same broad goal: better skin quality rather than added volume. Clinics that already offer Profhilo or other HA-based revitalisers may find collagen biostimulation a useful option for patients who prefer a non-HA approach, or as a complementary step within a broader rejuvenation programme.

The Takeaway

Linerase brings a genuinely different mechanism to the skin-quality category — direct collagen scaffolding rather than hydration — packaged as a structured, multi-step system that supports both in-clinic treatment and retail follow-through. Understanding how it compares with HA-based options helps practitioners position it accurately rather than as a generic "anti-ageing injectable."

To review the product specification, see Linerase Collagen Booster, or browse the wider skinboosters range for complementary skin-quality treatments.